| Ytd | 7.33% | |
| 1y | -49.39% |
| Open | 2.57 | Prev Close | 2.54 | Low | 2.48 | High | 2.58 | Mkt Cap | 6.12M |
| Vol | 7.63K | Avg Vol | 71.36K | EPS | -0.36 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.00 | Short Ratio | 3.35 | Inst. Own | 1.92% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.79 | 200-d Avg | 2.94 | 1yr Est | 0.00 |
XTLB News
Gainers Tenon Medical (NASDAQ:TNON) stock rose 122.5% to $12.13 during Wednesday's pre-market s
Gainers NextCure (NASDAQ:NXTC) shares rose 305.5% to $8.84 during Tuesday's pre-market session.
Gainers Crinetics Pharmaceuticals (NASDAQ:CRNX) stock increased by 98.9% to $83.59 during Tuesday&#
Gainers Can Fite Biopharma (AMEX:CANF) shares rose 43.8% to $4.27 during Wednesday's regular se
expands its IP portfolio to clinical-stage biopharmaceutical assets XTL Biopharmaceuticals (XTL) Com
Nasdaq informed the Company that this matter serves as an additional basis for delisting the Company
RAMAT GAN, ISRAEL, May 22, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:
US stocks lower, Dow falls 100 points. Energy shares up 1%, communication services down 0.7%. Brinke
XTL Biopharmaceuticals Ltd. (the "Company" or "XTL") announced today that it has ent
Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics
XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), a
RAMAT GAN, ISRAEL, March 20, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TAS
RAMAT GAN, ISRAEL, Feb. 27, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE
XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), a
RAMAT GAN, ISRAEL, Jan. 29, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE
XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), a
RAMAT GAN, ISRAEL, Jan. 23, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE
Beyond Air announces sale of 85% of NeuroNOS to XTL Biopharmaceuticals, gaining cash, shares, and mi
Unmatched scientific firepower: Two Nobel Laureates join Founder Prof. Haitham Amal, leading global
RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE
On December 5, 2025, XTL Biopharmaceuticals Ltd. (the "Company") announced that effective De
Brings a Wealth of Managerial Experience and Track Record RAMAT GAN, ISRAEL, April 07, 2025 (GLOBE N